Caffeine is a widely consumed substance, as its main intake reasons are its memory and concentration enhancing properties. Beside these well-known effects, there has been put forward a hypothesis that caffeine consumption along with antinociceptive medication can potentiate the analgesic effect of this class of drugs. Our aim was to point out the importance of this particular potentiator effect by selecting and analyzing all papers on this topic written in English from the Medline database, published until the present moment. We observed that caffeine can represent a significant aid for certain patients in matters of pain management, by both reducing the pain killer doses and by increasing life quality.
Category Archives: Number
Volume 66, Number 4, 2020
Erratum
This is a correction of the article The Statistical Analysis of Pharmacokinetic Parameters in the Context of Bioequivalence Testing of Two Anthelmintic Formulas Based on Ivermectine and Triclabendazole in Sheep (Acta Medica Marisiensis 2019;65(2):60-65. DOI: 10.2478/amma-2019-0015), published in the June 2019 issue of Acta Medica Marisiensis (currently Acta Marisiensis – Seria Medica), which contains errors in the authors’ affiliation. The correct data are presented below:
The Statistical Analysis of Pharmacokinetic
Parameters in the Context of Bioequivalence Testing of Two Anthelmintic Formulas Based on Ivermectine and Triclabendazole in Sheep
Lenard Farczadi1,2,3, Laurian Vlase2*, Orsolya Melles1, Ramona Tolomeiu4, Octavia Tamas-Krumpe4, Andreea Buta4, Laurentiu Ognean4
1. Clinical and Analytical Research Center Vim Spectrum Ltd, Sighișoarei Street, no. 409, 547367, Corunca – Mureș, Romania
2. Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, “Iuliu Haţieganu” University of Medicine and Pharmacy, Emil Isac street, no. 13, 400023, Cluj-Napoca, Romania
3. Center for Advanced Medical and Pharmaceutical Research of the George Emil Palade University of Medicine, Pharmacy, Science and Technology of Targu Mures, Romania
4. Department of Physiology, University of Agricultural Science and Veterinary Medicine, Mănăștur Street, no. 3-5, 400037, Cluj-Napoca, Romania
The Efficacy of Rational Emotive Behavior Therapy Intervention in Generalized Anxiety Disorder
Background: Generalized Anxiety Disorder is one of the anxiety disorders which presents excessive anxiety and worries as central elements that are difficult to control in many situations or activities. Rational Emotive Behavior Therapy is one of the most important orientations among psychological intervention in the psychotherapy field. This approach is based on a transdiagnostic perspective. Additionally, this therapy has a strong research foundation especially in the treatment of anxiety disorders and depression.
Objective: The present study aims to establish the efficacy of Rational Emotive Behaviour Therapy in medical students who are suffering from generalized anxiety disorder.
Method: The sample of this study consisted of N = 40 first-year medical students (33 women and 7 men) and the average age for the entire group was Mage= 19.22, SD= 1.04. Each student participated at eight therapy sessions. The level of anxiety and irrational beliefs were measured at pre-intervention and post-intervention using psychological questionnaires.
Results: Our findings indicate a statistically significant difference between the pre-intervention and post-intervention phase for the level of anxiety with a value of t = 20.31, df =78, P < 0.001, for irrational cognitions with t = 2.44, df =78, P < 0.05, for irrational beliefs with t = 3.45, df =77, P < 0.01, as well as low frustration tolerance with t = 2.57, df =77, P < 0.05 and awfulizing specifically.
Conclusion: The Rational Emotive Behavior Therapy intervention is an extremely efficient psychological treatment for improving emotional functioning in medical students.
Factors Influencing the Choice of a Pharmacy in Romania: Comparation between Studies Performed in 2012 and 2020
The main factors perceived by patients as important in selecting a pharmacy were studied for many years. Selected studies mentioned primarily factors such as location, pharmacist competence and attitude, pharmacy services and premiums, and prices. We compared the results from our study in June 2012 with the results of the most recent study conducted in April 2020 focusing on the main factors influencing the patient’s option for a specific pharmacy. Respondents were asked an open question about what is the most important factor they consider when choosing a pharmacy and then answers were grouped into main categories. The urban population has been considered for both studies. The results tell us that the factors influencing the choice of a pharmacy remained unchanged over the time: i) prices, ii) availability of medicine, iii) professionalism of the pharmacist and iv) pharmacy proximity is the most mentioned by our respondents in both studies. However, the rank between these factors changed. Prices remain the top factor while the Availability of medicine (products) has been overcome by the Professionalism of the pharmacist (Attitude of the pharmacist) and Proximity. Using the logistic regression and Odds Ratio, we tried to identify socio-demographic segments significantly associated with these factors. Persons with low income are very likely to indicate Price as the most important factor in choosing a pharmacy in 2012 (OR = 2.088, p=0.018), while respondents aged 65 years and older are more likely not to indicate Price as the most important factor compared with other age groups, in both 2012 and 2020 studies (OR = 0.4, p=0.009, respective OR= 0.325, p=0.010). For this type of respondent, 65 years old and above, the attitude of the pharmacist is the most important factor influencing their choice of a pharmacy in 2020, while products availability has been the most frequent answer for this segment back in 2012. Results in Romania are similar to the ones collected from other countries as reported by other studies. However, particularities of the local market and regulations are influencing the ranking.
Genitourinary Bacterial Infection: a Cause of Infertility in Men? A Cases Series and Short Review of Literature
Introduction: The role of bacterial infections on the onset and the development of male infertility is still highly controversial, as the clinical cases have different outcomes and the practitioners have no guidelines that will help them select the cases that could better benefit from antibiotic treatment.
Case presentation: Four case reports are presented in order to emphasize the possible clinical implications of genitourinary bacterial infections on male infertility. The first patient had two bacterial strains isolated from the semen culture, Escherichia coli, and then Enterococcus faecalis. The antibiotic treatment was not effective. The second patient had a semen culture positive with Enterococcus faecalis. The treatment was successful: the bacteria were eradicated and the patient was able to conceive a baby. Enterococcus faecalis was also identified in the third and the fourth case. These patients were able to conceive, despite the different clinical management strategies of the cases.
Conclusion: Bacterial prostatitis might play a role in male infertility, but the clinical cases are still highly unpredictable. Every case presents a different viewpoint and raises awareness of the complexity of the problem.
Ovarian Endometriosis and Malignant Transformation in Clear Cell Carcinoma
Atypical endometriosis is considered to be precursors for malignancy. Coexistence of atypical endometriosis and ovarian neoplasm has been found in some studies. We describe the case of a 48-year old women diagnosed with clear cell carcinoma of ovary. The review of histological slide confirms the presence of benign endometriosis in both ovaries, the atypical endometriosis and clear cell carcinoma in the right ovary and the presence of uterine leiomyoma.
Volume 66, Number 3, 2020
Controls in Real-Time Polymerase Chain Reaction Based Techniques
From its discovery in the 1980s, Polymerase chain reaction was further developed and is nowadays used as the foundation for the various PCR-based techniques used in molecular diagnosis across different species, and numerous types of samples. Real-Time PCR enables the user to monitor the amplification of a deoxyribonucleic acid (DNA) or complementary DNA (cDNA) target during the PCR run, in real-time, and not at the end, as it is the case in conventional PCR. The most frequent types of applications include gene expression analysis, gene silencing, variant analysis, and fusion temperature analysis. Given its vast field of application, a key question remains, and it is related to the controls (negative controls, positive controls, internal exogenous and endogenous controls) and their purpose in a Real-Time PCR experiment. In this paper, we set out to find how and when to use them, and which type of controls are suitable for certain experiment types, since the use of appropriate controls during Real-Time PCR experiments will reduce the effects of variables aside from the independent variable within the sample, therefore yielding accurate results, be it in research or diagnostic purposes.
SARS-CoV2 Infection in a Multiple Sclerosis Patient Treated with Natalizumab – A Case Presentation
Introduction: The novel coronavirus, SARS-CoV2, has rapidly spread worldwide and led to an intense collaboration among both physicians and researchers in order to stop its dissemination. Little is yet known about how this virus behaves, but recent studies have suggested the role of integrins in the viral penetration of target cells. Natalizumab is an anti-α4-β1 integrin monoclonal antibody used in the treatment of multiple sclerosis (MS), a neurodegenerative auto-immune disease affecting primarily young adults. MS patients have a greater susceptibility to develop severe infections especially enhanced by the disease-modifying therapies (DMTs) which are currently recommended for their treatment. Natalizumab is considered the safest high-efficacy DMT in times of COVID-19 outbreak.
Case presentation: We hereby describe the first case from Romania of a MS patient treated with Natalizumab who subsequently acquired SARS-CoV2 infection and whose recovery was excellent, with no functional neurological or respiratory sequelae.
Conclusion: The favourable evolution of our patient supports the potential therapeutic effect Natalizumab might have in SARS-CoV2 treatment by specifically blocking integrins and by its immunosuppressant characteristics.